InsiderOther

Anthony A. Florence Jr. Insider Trading Activity

Every SEC Form 4 transaction reported by Anthony A. Florence Jr., sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Is Anthony A. Florence Jr. buying or selling?

Anthony A. Florence Jr. reported 45 open-market buys ($283.7M) and 8 sells ($2.2M) across 53 Form 4 filings at 26 companies — a net buying position of $281.5M.

Source: SEC EDGAR Form 4

Key Statistics (as of Mar 13, 2026)

Total Form 4 filings
53
SEC EDGAR
Companies
26
Buys (45)
$283.7M
Sells (8)
$2.2M

Insider sentiment

Net buying

Net insider flow of $281.5M in net buying, filed between Feb 27, 2018 – Mar 13, 2026.

Companies Anthony A. Florence Jr. files for

#CompanyForm 4 filings
1AVEOAVEO PHARMACEUTICALS INC15
2ADAPYAdaptimmune Therapeutics PLC4
3GNCAGENOCEA BIOSCIENCES, INC.4
4TRVITrevi Therapeutics, Inc.4
5HOODRobinhood Markets, Inc.2
6KRROKorro Bio, Inc.2
7MTCRMetacrine, Inc.2
8RGLSRegulus Therapeutics Inc.2
9ACLXArcellx, Inc.1
10AKUSAkouos, Inc.1

Recent Anthony A. Florence Jr. transactions

DateTickerRoleTypeSharesValue
Mar 13, 2026KRRO10% OwnerPurchase207.1K$2.3M
Feb 11, 2026SGP10% OwnerPurchase937.5K$15.0M
Oct 6, 2025NEUEDirector, 10% OwnerSale4.2K$28.3K
Sep 18, 2024MBX10% OwnerPurchase500.0K$8.0M
Apr 24, 2024KRRO10% OwnerPurchase17.9K$1000.0K
Jul 19, 2023SVRA10% OwnerPurchase333.3K$1000.0K
Dec 22, 2022ACLX10% OwnerPurchase179$5.5K
May 26, 2022GNCA10% OwnerSale10.4M$750.7K
May 4, 2022HOODDirectorSale2.0K$19.6K
Apr 13, 2022TRVI10% OwnerPurchase3.6M$6.8M
Feb 2, 2022HOODDirectorSale2.1K$29.6K
Dec 27, 2021MTCR10% OwnerSale497.3K$494.5K
Oct 20, 2021TRVI10% OwnerPurchase1.9M$0
Jul 1, 2021BHG10% OwnerPurchase1.9M$35.0M
Jun 30, 2021GLUE10% OwnerPurchase1.1M$19.9M
Mar 18, 2021MRKR10% OwnerPurchase5.7M$10.0M
Dec 7, 2020RGLS10% OwnerPurchase4.4M$2.7M
Oct 22, 2020EAR10% OwnerPurchase311.1K$5.6M
Sep 22, 2020MTCR10% OwnerPurchase769.2K$10.0M
Jul 28, 2020INZY10% OwnerPurchase250.0K$4.0M
Jul 28, 2020GNCA10% OwnerPurchase3.2M$7.1M
Jul 16, 2020NKTX10% OwnerPurchase666.7K$12.0M
Jul 1, 2020AKUS10% OwnerPurchase588.2K$10.0M
Jun 22, 2020AVEO10% OwnerPurchase1.4M$7.5M
Apr 14, 2020MRSN10% OwnerSale20.9K$177.8K

Showing the 25 most recent filings of 53. Screen every filing.

Anthony A. Florence Jr. insider trading FAQ

Is Anthony A. Florence Jr. buying or selling?

Across 53 SEC Form 4 filings, Anthony A. Florence Jr. reported 45 open-market purchases totaling $283.7M and 8 sales totaling $2.2M — a net buying position of $281.5M.

Which companies does Anthony A. Florence Jr. file Form 4s for?

Anthony A. Florence Jr. has reported insider transactions at 26 companies, most often AVEO PHARMACEUTICALS INC (AVEO), Adaptimmune Therapeutics PLC (ADAPY), GENOCEA BIOSCIENCES, INC. (GNCA), Trevi Therapeutics, Inc. (TRVI), Robinhood Markets, Inc. (HOOD).

How far back does Anthony A. Florence Jr.'s filing history go?

Trabud holds Anthony A. Florence Jr.'s SEC Form 4 filings from Feb 27, 2018 – Mar 13, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Anthony A. Florence Jr.'s insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Anthony A. Florence Jr. and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener